Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 30, 2021

View Archived Issues

Glutamine promotes antibiotic uptake to kill MDR bacteria

NeoPhore patents DNA mismatch repair protein Mlh1/mismatch repair endonuclease PMS2 inhibitors

New transcriptional enhancer factor (TEAD) inhibitors identified at the Dana-Farber Cancer Institute

GB005 discovers Bruton tyrosine kinase inhibitors

New psychosine receptor modulators patented by Pathios Therapeutics

Merck & Co. divulges dual Toll-like receptor 7/8 agonists

Prolyl-tRNA synthetase linked to poor prognosis in multiple myeloma

Vaginal film loaded with hexavalent antisperm IgG shows potential as nonhormonal contraception

Bovine/human parainfluenza virus 3 vector SARS-CoV-2 vaccine shows promise in hamster model

Peripheral delivery of the brain permeable AMPK activator R-481 raises glycemia in rats

High-throughput screening assay to identify inhibitors of SARS-CoV-2 Mac1 macrodomain

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...